Archive · 31 Jul 2025
Mankind Pharma Reports Profit Decline Despite Revenue Surge in Q1
Mankind Pharma, a drug company, made less profit this past quarter compared to last year, even though they sold more products overall.
While their income went up a lot due to both local and international sales, their profits still went down.
The company's market share grew slightly, and they sold more in the country and in foreign markets, with their export business showing a big increase.
Specific products like condoms and other health items also sold well, making them a leader in the pharmaceutical market.
Mankind Pharma's net profit decreased 18.1% year-on-year in Q1.
Revenue from operations surged 24.5% to ₹3,570 crore.
EBITDA increased 26% to ₹847.6 crore, with a slight margin improvement.
Domestic revenue rose 18.9%, while export revenue surged 81.1%.
The company's market share increased from 4.8% to 4.9%.
- Who
- Mankind Pharma Ltd, a pharmaceutical firm.
- What
- Mankind Pharma reported a decline in net profit despite strong revenue growth.
- When
- The report covers the first quarter of the fiscal year (Q1FY26).
- Where
- The company's operations are primarily in India and international markets.
- Why
- Net profit declined despite revenue growth due to various operational factors.
Company Performance
Market Position
Financial Results
Company Performance
Decline in Net Profit
Market Position
Strong Revenue Growth
- Net Profit (Q1FY26)
- ₹444.6 crore
- Net Profit (YoY Decline)
- 18.1%
- Revenue from Operations
- ₹3,570 crore
- Revenue Growth (YoY)
- 24.5%
- Export Revenue Growth
- 81.1%
- Market Share (June 2025)
- 4.9%